Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo

Melek M.E. Sunay, Jeremy B. Foote, James M. Leatherman, Justin P. Edwards, Todd D. Armstrong, Christopher J. Nirschl, Jessica Hicks, Leisha A. Emens

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Sorafenib combined with HER-2 targeted vaccination can promote effective T cell immunity in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences